Mylan NV (USD)
MYL
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range17.17 | 17.78
52-Wk Range16.63 | 36.94
Last Close17.53
Mkt Cap (m)9,047.80
Dividend yield-
ISINNL0011031208
Volume8,485,214
Exchange VenueNAS

Company Profile

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

Key Information
Price/Earning194.78
Price/Book0.79
Price/Sales0.79
P/CF5.16
Rev Growth (3 year avg)6.64
EPS Growth (3 year avg)-0.26
Operating Margin % 7.49
Net Margin %3.08
Return on Equity2.77
Debt/Equity1.14

Legal Documents

Prospectus
en 11/12/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)6,9097,7209,42911,07711,90811,434
Operating Income (m)1,1211,4011,3641,3741,424856
Net Income (m)624929848480696353
Basic EPS1.632.491.800.941.300.69
Avg. Diluted Shares Outstanding (m)394398497521537517
Balance Sheet
USD201320142015201620172018
Current Assets (m)4,4716,7876,4737,5237,2136,368
Non Current Assets (m)10,7659,10015,79527,20428,59326,367
Total Assets (m)15,23615,88722,26834,72635,80632,735
Current Liabilities (m)2,9565,3064,1225,0416,3854,588
Total Liabilities (m)------
Total Equity (m)2,9423,2569,76411,11613,30812,167
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)1,1071,0152,0092,0472,0652,342
Capital Expenditure (m)-335-754-872-751-896-1,196
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
17.53
Last Price